What are the indications for combined intravenous alteplase (tPA) thrombolysis and mechanical thrombectomy in acute ischemic stroke due to large‑vessel occlusion?

Combined Thrombolysis and Mechanical Thrombectomy in Acute Stroke

Eligible patients should receive IV alteplase even if mechanical thrombectomy is being considered, and you should NOT wait to evaluate the response to IV thrombolysis before proceeding with catheter angiography for mechanical thrombectomy. 1

Core Indication for Combined Therapy

The primary indication for combined IV alteplase and mechanical thrombectomy is acute ischemic stroke due to large vessel occlusion (LVO) in patients who meet eligibility criteria for BOTH treatments and present within the appropriate time windows.

Specific Criteria for Combined Therapy:

For IV Alteplase Component:

• Treatment can be initiated within 4.5 hours of symptom onset (or last known well) 1
• No contraindications to IV thrombolysis
• Blood pressure controlled below 185/110 mmHg 1
• Blood glucose checked (only mandatory pre-treatment assessment) 1

For Mechanical Thrombectomy Component (0-6 hours):

• Age ≥18 years
• Pre-stroke mRS score 0-1
• Causative occlusion of internal carotid artery or MCA (M1)
• NIHSS score ≥6
• ASPECTS ≥6
• Groin puncture can be initiated within 6 hours of symptom onset 1

For Extended Window (6-24 hours):

• LVO in anterior circulation
• Sizable mismatch between ischemic core (by CTP or MRI-DWI) and either clinical deficits or area of hypoperfusion 1
• Meet DAWN or DEFUSE 3 eligibility criteria 2

Critical Workflow Principle

Do NOT delay mechanical thrombectomy to assess response to IV alteplase. 1 This is a strong recommendation across all major guidelines. The two therapies should proceed in parallel, not sequentially. Start the alteplase bolus and immediately prepare for catheter angiography.

Evidence Nuances

The 2023 World Stroke Organization guidelines 1 provide the most current framework, strongly recommending combined therapy as standard practice. However, recent research 3, 4 suggests that mechanical thrombectomy alone may be non-inferior to combined therapy, with a 2026 meta-analysis showing no significant difference in functional independence (48.1% vs 51.2%, RR 0.94,95% CI 0.87-1.01) 3. Despite this emerging evidence, current guidelines still recommend combined therapy because:

• The evidence for harm from adding IV alteplase is minimal
• Some studies suggest improved microvascular reperfusion with combined therapy 5
• Bridging therapy may reduce the number of device passes needed 6
• There is no increased risk of symptomatic intracranial hemorrhage with combined therapy 7, 6

Special Circumstances

Contraindications to IV alteplase: If the patient has contraindications to IV thrombolysis but is eligible for mechanical thrombectomy, proceed with mechanical thrombectomy alone 8, 9

Basilar artery occlusion: For patients with BAO presenting within 4.5 hours without extensive posterior circulation ischemic changes, expert consensus supports IV thrombolysis before thrombectomy, though the evidence base is weaker than for anterior circulation 10

Extended time windows (4.5-9 hours): Consider IV alteplase if CT or MRI shows core/perfusion mismatch AND mechanical thrombectomy is either not indicated or not planned 1

Common Pitfalls to Avoid

1. Delaying thrombectomy to see if alteplase works - This defeats the purpose of combined therapy and worsens outcomes
2. Withholding alteplase because thrombectomy is planned - Unless contraindicated, give both treatments
3. Extensive pre-treatment testing - Only blood glucose must be checked before alteplase; other labs should not delay treatment 1
4. Excluding patients with severe strokes (NIHSS >25) - These patients may still benefit from combined therapy if presenting early 1